Dimethyl Fumarate

CAS 624-49-7 23 API suppliersSmall Molecule

Overview

Dimethyl fumarate is an orally bioavailable small molecule with immunomodulatory properties. It is used primarily for the treatment of multiple sclerosis.

API suppliers (23)

Suppliers of Dimethyl Fumarate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

Where these suppliers are
India14Netherlands2China2Germany1

Country recorded for 19 of 23 suppliers.

15 of 23 hold a GMP certificate on record in the EU or UK registers

Therapeutic areas

NeurologyAutoimmune DiseasesMultiple Sclerosis
Verified Supplier Partner

Do you supply Dimethyl Fumarate? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.